28 results
8-K
EX-99.1
ARVN
Arvinas Inc
16 May 24
Regulation FD Disclosure
6:05am
of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets … of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support
8-K
EX-99.1
ARVN
Arvinas Inc
7 May 24
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:02am
value for Arvinas and further validates our innovative PROTAC protein degrader platform and its potential to deliver important new treatment options
8-K
EX-99.1
ARVN
Arvinas Inc
11 Apr 24
Entry into a Material Definitive Agreement
7:03am
transaction also further validates our innovative PROTAC protein degrader platform and its potential to deliver new treatments.” Under the terms
8-K
EX-99.1
i7486lx01e9 aleis
6 Dec 23
Regulation FD Disclosure
7:01am
8-K
EX-99.1
z870hvebk4 zfnp3n
7 Nov 23
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:03am
8-K
EX-99.1
739yz8sc0zh2ff h9sou
23 Oct 23
Regulation FD Disclosure
8:30am
8-K
EX-99.1
uh1zmr59tuwll 7fr0l
8 Aug 23
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:03am
8-K
EX-99.1
d9dlg
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
EX-99.1
5vu89dtxi 7zxtrk35uq
9 Nov 22
Arvinas Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:28am
8-K
EX-99.1
hlvxw2o6jt3vzri89 vn
5 Aug 22
Arvinas Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:12pm
8-K
EX-99.1
pflbf443kzrpnq81
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
EX-99.1
bojt22hm x7n8sh4
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am